Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

GSK's vaccine sales, including RSV and Shingrix, decline amid changing US recommendations, impacting Q3 performance and ...

This writer thinks GSK shares appear very cheap after the Q3 results, making him wonder if now's the time for him to invest ...

Harvey Jones reckons this former FTSE 100 darling could be the best share for him to buy today given its low price and rising ...

Discover the major biotech partnerships, collaborations, and mergers and acquisitions that made headlines in October 2024.

Rolling coverage of the latest economic and financial news, as City investors anticipate tax rises in Rachel Reeves first ...

CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced its financial results for the ...

Ionis has five FDA-approved drugs and promising upcoming approvals. See more about IONS stock and why it warrants a Buy ...

As of September 30, 2024, Zymeworks has repurchased 1,818,530 shares of the Company's common stock for a cost of $20.6 ...

Reeves introduced tax increases in the form of higher National Insurance contributions, as well as a higher minimum wage and ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

KellyFact checked by Vikki VelasquezAmerican taxpayers complain about a wide range of tax features but studies by the Pew Research Center consistently reveal that a majority express concern that some ...